Metronidazole Tablets and Capsules manufacturers & suppliers

Metronidazole Tablets And Capsules

Form: Oral Tablets and Capsules

Strength: 250 mg, 500 mg

Reference Brands: Flagyl(US)

Category: Medical Aid

Metronidazole tablets are approved in the EU and US for anaerobic bacterial and protozoal infections. In the EU, brands like Flagyl are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic options widely available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for metronidazole tablets, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Chlorhexidine Solutions

Strength: 0.12% or 2%

Form: Solutions for disinfection

Reference Brands: Peridex, Periogard(US)

View Details
Hydrochlorothiazide Tablets

Strength: 12.5 mg, 25 mg, 50 mg

Form: Tablet

Reference Brands: Microzide, HydroDiuril(US)

View Details
Lisinopril Tablets

Strength: 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg

Form: Tablet

Reference Brands: Prinivil, Zestril(US & EU)

View Details
Enalapril Tablets

Strength: 2.5 mg, 5 mg, 10 mg, 20 mg

Form: Tablet

Reference Brands: Vasotec(US)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.